Continual exposure can generate protection against malaria and can be acquired through an exposure to a high number of infectious mosquito bites. Parasites that are injected by a mosquito first migrate to the liver where they mature and then are released into the blood circulation and it is only here that they cause disease and fatal complications.
A very promising method for vaccination is to sufficiently weaken parasites such that they invade liver cells but then are not able to develop any further. It is, however, required that these attenuated parasites are still able to stimulate a good immune response in the liver. This can be achieved by irradiating the parasites or by genetically inactivating individual parasite genes that are active during the parasites growth in the liver. Researchers from Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands and LUMC, Leiden, the Netherlands, have now characterized a large number of parasite proteins (‘proteome’) that are present only during liver stage development and therefore are potential targets for inactivation.
The research groups had previously shown that protection in mice can be achieved by vaccinating mice with a rodent malaria which had one of these liver stage genes removed, specifically p36p. Moreover, the protection was long lasting and virtually complete. Now, these same researchers from Nijmegen and Leiden have succeeded in making the first critical transition from the rodent system to humans by inactivating the equivalent gene (p52) in the most important human malaria parasite, P. falciparum. Similar to the results with the rodent parasite, these human parasites are unable to develop in liver cells. This is the first time that genetic modification of a human parasite results in its growth arrest in a liver cell, opening up exciting possibilities for its use as a human vaccine.
These studies form part of a collaborative project with the American company Sanaria (www.sanaria.com), whose sole purpose is develop a whole organism malaria parasite vaccine for use in humans, and is funded by TI-Pharma. These studies show how results obtained in rodent models of malaria can be pipelined to form the basis for clinical development of anti-malaria vaccines in humans.
prof.dr. Robert Sauerwein | alfa
Lethal combination: Drug cocktail turns off the juice to cancer cells
12.12.2018 | Universität Basel
Smelling the forest – not the trees
12.12.2018 | Universität Konstanz
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
12.12.2018 | Health and Medicine
12.12.2018 | Physics and Astronomy
12.12.2018 | Health and Medicine